{"result":[{"lastName":"Efron","clinicalFocus":[],"appointments":[{"appointment":"Professor,Statistics"},{"appointment":"Professor,Health Research & Policy - Biostatistics"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Statistics","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6090&type=small&showNoImage","displayName":"Bradley Efron","firstName":"Bradley","href":"http://med.stanford.edu/profiles/cvi/researcher/Bradley_Efron","researchInterest":"Theories of inference applied to biostatistical data;, the bootstrap method."},{"lastName":"Holodniy","clinicalFocus":[{"focus":"Infectious Disease"},{"focus":"Infectious Diseases"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Infectious Diseases"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Infectious Diseases","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4021&type=small&showNoImage","displayName":"Mark Holodniy","firstName":"Mark","href":"http://med.stanford.edu/profiles/cvi/researcher/Mark_Holodniy","researchInterest":"My research program is currently focused in three areas: 1) translational research (HCV/HIV viral evolution and antiviral resistance prevalence and development), 2) HIV/HCV clinical trials (diagnostic assay/medical device, antiretrovirals, ARVs and immunomodulators), and 3) health services research focusing on cost effectiveness of HIV antibody and ARV resistance testing and ARV utilization and clincal outcome."},{"lastName":"Sikic","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"New Drug Studies"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4131&type=small&showNoImage","displayName":"Branimir I. Sikic, M. D.","firstName":"Branimir","href":"http://med.stanford.edu/profiles/cvi/researcher/Branimir_Sikic","researchInterest":"Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, clinical trials of modulation of drug resistance, general oncology, Phase I trials of new drugs, gene expression profiling of cancers"},{"lastName":"Katzenstein","clinicalFocus":[],"appointments":[{"appointment":"Professor (Research),Medicine - Infectious Diseases"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor (Research),Medicine - Infectious Diseases","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4325&type=small&showNoImage","displayName":"David Katzenstein","firstName":"David","href":"http://med.stanford.edu/profiles/cvi/researcher/David_Katzenstein","researchInterest":"Treatment and evaluation of HIV infectionin the United States and Europe through the AIDS Clinical Trials Group (ACTG). International HIV pathogenesis work includes studies in Zimbabwe, South Africa, and India where we are particularly interested in the pandemic of subtype C HIV-1, TB and other co-infections. The lab currently is focused on drug resistance, envelope tropism and the pathogenesis of HIV."},{"lastName":"Zolopa","clinicalFocus":[{"focus":"Infectious Disease"},{"focus":"Infectious Diseases"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Infectious Diseases"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Infectious Diseases","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4034&type=small&showNoImage","displayName":"Andrew Zolopa","firstName":"Andrew","href":"http://med.stanford.edu/profiles/cvi/researcher/Andrew_Zolopa","researchInterest":"Dr. Zolopa\u0092s research applies a variety of clinical epidemiologic methods in an effort to optimize antiretroviral therapy and understand the impact of drug resistance on response to ARV.   Areas of focus include the clinical application of resistance testing in optimizing antiretroviral therapy, clinical cohort and trials of antiretroviral therapies and population-based epidemiologic evaluation of HIV resistance and efficacy of ARV therapy in urban poor communities of San Francisco."},{"lastName":"Pizzo","clinicalFocus":[{"focus":"Infectious Diseases, Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Dean of the School of Medicine,Stanford University School of Medicine"},{"appointment":"Professor,Pediatrics"},{"appointment":"The Carl and Elizabeth Naumann Dean,Stanford University School of Medicine"},{"appointment":"Professor,Microbiology & Immunology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Dean of the School of Medicine,Stanford University School of Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3843&type=small&showNoImage","displayName":"Philip A. Pizzo, M.D.","firstName":"Philip","href":"http://med.stanford.edu/profiles/cvi/researcher/Philip_Pizzo","researchInterest":""},{"lastName":"Cooke","clinicalFocus":[{"focus":"Cardiology (Heart)"},{"focus":"Cardiology (Heart), Preventive"},{"focus":"Cardiovascular Disease"},{"focus":"Vascular Medicine"}],"appointments":[{"appointment":"Professor,Medicine - Cardiovascular Medicine"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor,Medicine - Cardiovascular Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4115&type=small&showNoImage","displayName":"John Cooke, MD, PhD","firstName":"John","href":"http://med.stanford.edu/profiles/cvi/researcher/John_Cooke","researchInterest":"Our translational research program involves molecular, cellular, animal and human studies of endothelial biology. We are focused on the role of nitric oxide synthase (NOS) in atherosclerosis and angiogenesis.  A new focus of investigation has resulted from our discovery of a novel angiogenic pathway mediated by endothelial nicotinic cholinergic receptors (nAChR). We use a wide variety of tools and approaches to investigate the role of NOS and nAChR pathways in cardiovascular biology and disease."},{"lastName":"Shafer","clinicalFocus":[{"focus":"Infectious Disease"}],"appointments":[{"appointment":"Associate Professor (Research),Medicine - Infectious Diseases"},{"appointment":"Associate Professor (Research) (By courtesy),Pathology"}],"primaryAppointment":"Associate Professor (Research),Medicine - Infectious Diseases","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4054&type=small&showNoImage","displayName":"Robert W. Shafer","firstName":"Robert","href":"http://med.stanford.edu/profiles/cvi/researcher/Robert_Shafer","researchInterest":"Dr Shafer's research is on the mechanisms and consequences of HIV evolution with an emphasis on HIV drug resistance. He maintains an online database (http://hivdb.stanford.edu) designed to provide a publicly available resource for those performing HIV drug resistance surveillance, interpreting HIV drug resistance tests, and developing new antiretroviral drugs."},{"lastName":"Tsao","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor (Research),Medicine - Cardiovascular Medicine"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor (Research),Medicine - Cardiovascular Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4070&type=small&showNoImage","displayName":"Philip S. Tsao, PhD","firstName":"Philip","href":"http://med.stanford.edu/profiles/cvi/researcher/Philip_Tsao","researchInterest":""},{"lastName":"Fortmann","clinicalFocus":[{"focus":"Cardiology (Heart), Preventive"},{"focus":"Internal Medicine"},{"focus":"Primary Prevention"}],"appointments":[{"appointment":"Professor,Medicine - Stanford Prevention Research"},{"appointment":"Professor (By courtesy),Health Research & Policy"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Medicine - Stanford Prevention Research","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4619&type=small&showNoImage","displayName":"Stephen P. Fortmann, MD","firstName":"Stephen","href":"http://med.stanford.edu/profiles/cvi/researcher/Stephen_Fortmann","researchInterest":"Population-level (community) prevention of cardiovascular disease, epidemiology and prevention of chronic diseases, tobacco use cessation research, tobacco control policy, nutrition education, blood pressure control, and lipid disorders."},{"lastName":"Horning","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease - Blood and Marrow Transplant"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Leptommeningeal Disease"},{"focus":"Leptommeningeal Disease - Medical Oncology"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Blood and Marrow Transplant"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"}],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Medicine - Oncology"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4106&type=small&showNoImage","displayName":"Sandra Horning","firstName":"Sandra","href":"http://med.stanford.edu/profiles/cvi/researcher/Sandra_Horning","researchInterest":"Clinical Interests: Hodgkin's disease and non-Hodgkin's lymphoma. Research Interests: clinical trials in Hodgkin's disease and malignant lymphoma including high dose therapy and autografting, complications of cytotoxic therapy, novel therapeutics, and clinicopathologic correlations."},{"lastName":"Grant","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Medical fellow, Medicine"}],"primaryAppointment":"Postdoctoral Medical fellow, Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=9694&type=small&showNoImage","displayName":"Philip Grant","firstName":"Philip","href":"http://med.stanford.edu/profiles/cvi/researcher/Philip_Grant","researchInterest":""},{"lastName":"Pearl","clinicalFocus":[{"focus":"Anesthesia"},{"focus":"Critical Care Medicine"}],"appointments":[{"appointment":"Professor,Anesthesia"}],"primaryAppointment":"Professor,Anesthesia","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4680&type=small&showNoImage","displayName":"Ronald Pearl","firstName":"Ronald","href":"http://med.stanford.edu/profiles/cvi/researcher/Ronald_Pearl","researchInterest":"Mechanims (molecular and cellular) of pulmonary hypertension, treatment of pulmonary hypertension, treatment of respiratory failure, treatment of septic shock, hemodynamic monitoring"},{"lastName":"Patterson","clinicalFocus":[{"focus":"Anesthesia"},{"focus":"Critical Care Medicine"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Anesthesia"},{"appointment":"Associate Professor - Med Center Line (By courtesy),Surgery"}],"primaryAppointment":"Associate Professor - Med Center Line,Anesthesia","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6059&type=small&showNoImage","displayName":"Andrew J. Patterson, M.D., Ph.D.","firstName":"Andrew","href":"http://med.stanford.edu/profiles/cvi/researcher/Andrew_Patterson","researchInterest":"Critical Care Medicine,\r\nCardiovascular Pharmacology,\r\nAdrenergic Receptors,\r\nCongestive Heart Failure,\r\nVascular Biology,\r\nCardiopulmonary Physiology,\r\nSepsis"},{"lastName":"Kobilka","clinicalFocus":[],"appointments":[{"appointment":"Professor,Molecular & Cellular Physiology"},{"appointment":"Professor,Medicine"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor,Molecular & Cellular Physiology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4300&type=small&showNoImage","displayName":"Brian Kobilka","firstName":"Brian","href":"http://med.stanford.edu/profiles/cvi/researcher/Brian_Kobilka","researchInterest":"Structure, function and physiology of adrenergic receptors."},{"lastName":"Killen","clinicalFocus":[],"appointments":[{"appointment":"Professor (Research),Medicine - Stanford Prevention Research"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor (Research),Medicine - Stanford Prevention Research","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4660&type=small&showNoImage","displayName":"Joel Killen","firstName":"Joel","href":"http://med.stanford.edu/profiles/cvi/researcher/Joel_Killen","researchInterest":"My research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults."},{"lastName":"Stockerl-Goldstein","clinicalFocus":[],"appointments":[{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Member,Cancer Center","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4547&type=small&showNoImage","displayName":"Keith Stockerl-Goldstein, M.D.","firstName":"Keith","href":"http://med.stanford.edu/profiles/cvi/researcher/Keith_Stockerl-Goldstein","researchInterest":"Clinical investigation of bone marrow and peripheral blood progenitor cell transplantation for lymphoproliferative disease and solid tumors; immunotherapy following high-dose therapy and transplantation; supportive care following transplantation; immune system reconstitution."},{"lastName":"Blume","clinicalFocus":[],"appointments":[{"appointment":"Emeritus (Active) Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Emeritus (Active) Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4180&type=small&showNoImage","displayName":"Karl Blume","firstName":"Karl","href":"http://med.stanford.edu/profiles/cvi/researcher/Karl_Blume","researchInterest":"Allogeneic and autologous bone marrow transplantation (experimental and clinical) as a treatment modality for leukemia, lymphoma, Hodgkin's disease, multiple myeloma, hereditary disorders, immune defects and selective solid tumors. Development of novel preparatory regimens to prevent the recurrence of the underlying malignancies. Studies for the prevention of acute and chronic graft-versus-host disease. Testing of new anti-viral agents to prevent or treat viral infections."},{"lastName":"Bernstein","clinicalFocus":[{"focus":"Pediatric Cardiology"},{"focus":"Pediatric Heart Transplantation"},{"focus":"Pediatric Heart Failure"}],"appointments":[{"appointment":"Professor,Pediatrics - Cardiology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Pediatrics - Cardiology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4174&type=small&showNoImage","displayName":"Daniel Bernstein","firstName":"Daniel","href":"http://med.stanford.edu/profiles/cvi/researcher/Daniel_Bernstein","researchInterest":"We are interested in the role of the sympathetic nervous system and its cellular components (adrenergic receptors, G proteins) in regulating cardiac development and function. We utilize gene knockout models to study the role of crosstalk between adrenergic receptors and other signaling pathways (MAPK,Akt,PKC) and in the regulation of intracellular and intramitochondrial calcium. We also develop tools for examination of cardiovascular physiologic parameters in transgenic and knockout mice."},{"lastName":"Dorenbaum","clinicalFocus":[{"focus":"Allergy and Immunology"}],"appointments":[{"appointment":"Clinical Associate Professor,Pediatrics - Allergy & Clinical Immunology"}],"primaryAppointment":"Clinical Associate Professor,Pediatrics - Allergy & Clinical Immunology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6765&type=small&showNoImage","displayName":"Alejandro Dorenbaum","firstName":"Alejandro","href":"http://med.stanford.edu/profiles/cvi/researcher/Alejandro_Dorenbaum","researchInterest":""},{"lastName":"Negrin","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"}],"appointments":[{"appointment":"Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Professor,Medicine - Division: Blood and  \r\nMarrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4138&type=small&showNoImage","displayName":"Robert Negrin","firstName":"Robert","href":"http://med.stanford.edu/profiles/cvi/researcher/Robert_Negrin","researchInterest":"Our labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells."},{"lastName":"Lacayo","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Pediatrics - Hematology/Oncology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Pediatrics - Hematology/Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=5921&type=small&showNoImage","displayName":"Norman J. Lacayo, MD","firstName":"Norman","href":"http://med.stanford.edu/profiles/cvi/researcher/Norman_Lacayo","researchInterest":"Pediatric Hematology/Oncology, Phase I drug studies for refractory and relapsed leukemia; genomic studies, biologic risk-stratification and treatment of acute myeloid leukemia."},{"lastName":"Patterson","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Associate Professor - Med Center Line (By courtesy),Medicine"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3975&type=small&showNoImage","displayName":"Bruce Patterson","firstName":"Bruce","href":"http://med.stanford.edu/profiles/cvi/researcher/Bruce_Patterson","researchInterest":"Our laboratory focuses on host-viral interactions in the sexual and mother-to-child transmission of HIV-1. We developed human organotypic models to closely mimic in vivo infection. Our recent work has focused on developing immune-based and small molecule inhibitors of HIV-1 transmission."},{"lastName":"Advani","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Cancer Center"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4018&type=small&showNoImage","displayName":"Ranjana Advani","firstName":"Ranjana","href":"http://med.stanford.edu/profiles/cvi/researcher/Ranjana_Advani","researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology."},{"lastName":"Rosenthal","clinicalFocus":[{"focus":"Anesthesia"},{"focus":"Critical Care Medicine"}],"appointments":[{"appointment":"Emeritus (Active) Professor,Anesthesia"}],"primaryAppointment":"Emeritus (Active) Professor,Anesthesia","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3787&type=small&showNoImage","displayName":"Myer \"Mike\" Rosenthal","firstName":"Myer","href":"http://med.stanford.edu/profiles/cvi/researcher/Myer_Rosenthal","researchInterest":""}]}